# Gastroenterology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charles Darwin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI003-SYN
- Date: 2026-04-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Mei-Ling Zhou, MD
- Calendar frame: modern shifted

- Requested by: Bernard Ashworth, MD

## Reason for consultation

Recurrent stereotyped episodes of nausea and vomiting for more than a year in a 40-year-old man, about every one to three weeks and almost weekly this winter. Please advise whether this is cyclic vomiting syndrome, whether the work-up is complete, and on prophylaxis, abortive treatment, and an emergency plan. **S**

## History

Mr. Darwin, a 40-year-old writer and naturalist, is seen at the request of Dr. Ashworth for more than a year of stereotyped vomiting episodes. His diary shows three episodes in the six weeks since his first visit, each 18 to 30 hours, after a prodrome of nausea, sweating, trembling, palpitations, and a swimming head lasting half an hour to an hour. Vomiting is frequent at the peak, then he sleeps. Between episodes he does not vomit, though he has wind and tires by the afternoon. Episodes follow social evenings, travel, short nights, and missed meals. He has no headaches with or between episodes, no dizziness on standing, and no weight loss, nocturnal pain, or blood. He has never used cannabis, by any route, and does not bathe compulsively. He drinks little alcohol and takes no medicines. He worries about being taken ill in company and has begun to avoid gatherings. **S**

## Examination

| System | Finding |
|---|---|
| General | Well between episodes; weight 71.4 kg |
| Cardiovascular | Regular rhythm at 76 per minute; blood pressure 116/72 mmHg, with no drop on standing |
| Abdomen | Soft and non-tender; no distension, masses, organ enlargement, or succussion splash; normal bowel sounds |
| Neurological | Cranial nerves and gait normal; no nystagmus |

BP 116/72 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 71.4 kg; BMI 21.3 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Ashworth's evaluation six weeks ago, including the diary format, blood count, metabolic and liver panels, lipase, TSH, morning cortisol, celiac serology, urinalysis, the ECG (QTc 412 ms), GAD-7 8, and PHQ-9 6; the CT enterography report from four weeks ago (normal small and large bowel, no obstruction, malrotation, or stricture, normal solid organs); the upper endoscopy report and duodenal biopsy result from two weeks ago (normal); and today's vital signs. 

## Assessment

1. **Cyclic vomiting syndrome, provisional** (R11.15). He meets the Rome IV criteria: stereotyped episodes of acute-onset vomiting lasting less than a week, well over three in the past year and two in the past six months, at least a week apart, with no vomiting between episodes, and onset more than three months ago. The prodrome, the triggers, and relief with sleep in a dark room are typical. Cannabinoid hyperemesis syndrome is excluded by his history. With episodes every one to three weeks that stop his work, it is moderate to severe. The diagnosis is clinical, with no confirmatory test, so it is recorded as provisional and should be revisited if the pattern changes. **S**
2. **Work-up**. Complete. The blood and urine tests, CT enterography, and upper endoscopy exclude obstruction, malrotation, mucosal disease, pancreatitis, celiac disease, and thyroid, adrenal, and metabolic causes. A gastric emptying study is not needed, as he has no symptoms of gastroparesis between episodes, and brain imaging is not needed without headache or neurological signs. Repeat testing is not advised unless an episode is atypical. **S**
3. **Prophylaxis**. A tricyclic is first line for moderate-to-severe disease. Amitriptyline at about 1 to 1.5 mg/kg is the usual effective dose, which for him is 75 to 100 mg at bedtime. His baseline QTc of 412 ms allows it. Coenzyme Q10 and riboflavin are conditional options that can be added later if the response is partial; topiramate or aprepitant are alternatives if amitriptyline fails or is not tolerated. **S**
4. **Abortive treatment**. Nasal sumatriptan with an ondansetron dissolving tablet, taken together within the first 30 to 45 minutes of the prodrome, works best. He has no heart disease, uncontrolled hypertension, or stroke that would rule out a triptan. The serotonin syndrome risk with amitriptyline is low at these doses, and he was told its warning signs. **S**
5. **Anxiety and triggers**. Mild anxiety (GAD-7 8) centered on episodes, without low mood. Anxiety and stress both trigger episodes and follow from them, so relaxation training and cognitive behavioral therapy are worthwhile alongside medicine. No anxiety disorder is diagnosed. **S**

## Recommendations

1. Amitriptyline 25 mg at bedtime, raised by 25 mg every two weeks to 75 mg; ECG at about 50 mg and at 75 mg, keeping the QTc below 450 ms; judge the response after three months at the target dose and continue for at least a year if it helps.
2. Sumatriptan 20 mg nasal spray with ondansetron 8 mg dissolving tablet at the first sign of the prodrome; the spray may be repeated once after 2 hours, no more than 6 sprays a week.
3. Emergency department letter: intravenous fluids with dextrose, intravenous ondansetron, lorazepam 1 to 2 mg if needed, a dark quiet room, a check of electrolytes and lipase, and opioids used sparingly.
4. Trigger plan: regular small meals, regular sleep, planning around travel and social events, and early treatment of infections; continue to avoid cannabis.
5. Relaxation breathing now, and cognitive behavioral therapy if he is willing.
6. Keep the symptom diary and bring it to each visit.
7. No further tests now; no gastric emptying study or brain imaging.
8. Primary care review at about three months and six months; gastroenterology review if there is no response after three months at the target dose, or if the pattern changes.

## Strengths and supports

- Supports: a settled household, absorbing scientific work, daily walks, and a habit of keeping careful notes that suits a symptom diary **S**

## Communication

Discussed with Dr. Ashworth, who sees him the same day. The provisional nature of the diagnosis, the reason for prophylaxis, and the abortive and emergency plans were explained to Mr. Darwin, who asked for the plan in writing and agreed to it. **S**

## Follow-up

Gastroenterology review as needed: if there is no response after three months at 75 mg, if episodes change in character, or if side effects prevent the dose from being reached. **S**

## Guideline basis

- Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019), American Neurogastroenterology and Motility Society and Cyclic Vomiting Syndrome Association (Neurogastroenterology & Motility)
- Anxiety Disorders in Adults: Screening (2023), U.S. Preventive Services Task Force
